Role of Mitochondrial tRNA <sup>Leu</sup> 12320 A&gt;G Mutation on Heart Rate Variability and Blood Pressure at Low-Altitude and in a High-Altitude Hypoxic Environment

Pan, Cuiping, Qunyuan Wang, Minglei Zhang, Ruizhe Li, Yining Liu, and Zongbin Li. Role of Mitochondrial tRNA Leu 12320 A&gt;G Mutation on Heart Rate Variability and Blood Pressure at Low Altitude and in a High-Altitude Hypoxic Environment. High Alt Med Biol. 00:00–00, 2025. Introduction: Mutations—gene mutations—can exert dual, environment-dependent effects on cardiovascular disease. Materials and Methods: We analyzed clinical data and mitochondrial DNA from 84 young Han Chinese men ascending from low-altitude to high-altitude regions (&gt;4,000 m). Results: Nine subjects harbored the mitochondrial tRNA A12320G mutation. Notably, none of these 9 mutation carriers developed acute mountain sickness (AMS), whereas 34 (40.5%) of the 84 volunteers in the cohort were diagnosed with AMS, indicating a significant protective association ( p = 0.009 ). In the low-altitude environment, time domain parameters of heart rate variability (HRV) in the mutant volunteers were significantly lower than those in the unmutated volunteers (SDNN: 141.76 ± 30.75 ms vs.169.08 ± 32.83 ms, p = 0.020; RMSSD: 29.70 ms vs. 41.35 ms, p = 0.022; HRV triangular index: 41.8% vs. 52.4%, p = 0.024; SDSD: 37.4 ms vs. 50.5 ms, p = 0.016; PNN50: 3.1% vs 7.6%, p = 0.008); 24-hour mean systolic blood pressure (118.63 ± 9.54 vs. 113.39 ± 6.30 mmHg, p = 0.029), nocturnal mean diastolic blood pressure (67.37 ± 7.91 vs. 61.11 ± 7.08 mmHg, p = 0.015) were also higher; HRV and blood pressure were not statistically different between the mutant and nonmutant groups in the high-altitude environment. Hematological analysis revealed mutants at high altitude had significantly lower plateletcrit (0.23% vs. 0.26%, p = 0.019) and total protein (72.78 ± 3.84 g/L vs.75 .65 ± 3.0 g/L, p = 0.008). Conclusion: The A12320G mutation acts as a cardiovascular risk factor (reduced HRV, increased blood pressure) at low altitude, whereas at high altitude it was associated with a reduced incidence of AMS, possibly through metabolic adaptive mechanisms, reflecting the environmentally dependent dual roles of this gene effect.

Authors

Institutions

Publication Details

Journal
High Altitude Medicine & Biology
Published
2026-01-09
DOI
https://doi.org/10.1177/15578682251411931
Primary Topic
High Altitude and Hypoxia
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Role of Mitochondrial tRNA Leu 12320 A>G Mutation on Heart Rate Variability and Blood Pressure at Low-Altitude and in a High-Altitude Hypoxic Environment

Qunyuan Wang, Cuiping Pan, Yang Liu, Ruizhe Li et al.
High Altitude Medicine & Biology
High Altitude and Hypoxia
article

Role of Mitochondrial tRNA Leu 12320 A>G Mutation on Heart Rate Variability and Blood Pressure at Low-Altitude and in a High-Altitude Hypoxic Environment

Qunyuan Wang, Cuiping Pan, Yang Liu, Ruizhe Li, Minglei Zhang, Zongbin Li
article en

Abstract

Pan, Cuiping, Qunyuan Wang, Minglei Zhang, Ruizhe Li, Yining Liu, and Zongbin Li. Role of Mitochondrial tRNA Leu 12320 A&gt;G Mutation on Heart Rate Variability and Blood Pressure at Low Altitude and in a High-Altitude Hypoxic Environment. High Alt Med Biol. 00:00–00, 2025. Introduction: Mutations—gene mutations—can exert dual, environment-dependent effects on cardiovascular disease. Materials and Methods: We analyzed clinical data and mitochondrial DNA from 84 young Han Chinese men ascending from low-altitude to high-altitude regions (&gt;4,000 m). Results: Nine subjects harbored the mitochondrial tRNA A12320G mutation. Notably, none of these 9 mutation carriers developed acute mountain sickness (AMS), whereas 34 (40.5%) of the 84 volunteers in the cohort were diagnosed with AMS, indicating a significant protective association ( p = 0.009 ). In the low-altitude environment, time domain parameters of heart rate variability (HRV) in the mutant volunteers were significantly lower than those in the unmutated volunteers (SDNN: 141.76 ± 30.75 ms vs.169.08 ± 32.83 ms, p = 0.020; RMSSD: 29.70 ms vs. 41.35 ms, p = 0.022; HRV triangular index: 41.8% vs. 52.4%, p = 0.024; SDSD: 37.4 ms vs. 50.5 ms, p = 0.016; PNN50: 3.1% vs 7.6%, p = 0.008); 24-hour mean systolic blood pressure (118.63 ± 9.54 vs. 113.39 ± 6.30 mmHg, p = 0.029), nocturnal mean diastolic blood pressure (67.37 ± 7.91 vs. 61.11 ± 7.08 mmHg, p = 0.015) were also higher; HRV and blood pressure were not statistically different between the mutant and nonmutant groups in the high-altitude environment. Hematological analysis revealed mutants at high altitude had significantly lower plateletcrit (0.23% vs. 0.26%, p = 0.019) and total protein (72.78 ± 3.84 g/L vs.75 .65 ± 3.0 g/L, p = 0.008). Conclusion: The A12320G mutation acts as a cardiovascular risk factor (reduced HRV, increased blood pressure) at low altitude, whereas at high altitude it was associated with a reduced incidence of AMS, possibly through metabolic adaptive mechanisms, reflecting the environmentally dependent dual roles of this gene effect.

High Altitude Medicine & Biology
Anhui Medical University (CN), Nankai University (CN), Chinese PLA General Hospital (CN)
Openalex Percentile: Top 92%
High Altitude and Hypoxia
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.